Monitor for the definitive proxy statement (DEF 14A) and any disclosure of shareholder proposals or voting items. The recent cost reduction program may be a precursor to activist engagement or management restructuring proposals.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 30 $3.36entry
- T+1 · 7mo ago 0.00%α −0.22% · $3.36
- T+5 · 6mo ago +8.93%α +7.20% · $3.66
- T+20 · 6mo ago +9.23%α +4.26% · $3.67
- T+60 · 4mo ago +26.79%α +23.68% · $4.26
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MiMedx Group filed a DEFA14A (additional definitive proxy soliciting materials). The substantive content of the filing is unavailable as only cover page and encoded graphic images were provided. The filing follows an April 16 8-K announcing a cost reduction initiative expected to generate $40 million in annualized savings, including elimination of the COO role. Without readable proxy content, the specific proposals or solicitation matters cannot be determined.
Key Facts
- Filing type: DEFA14A (additional definitive proxy soliciting materials)
- Filed April 29, 2026, following an April 16, 2026 8-K announcing cost reduction and executive changes
- Prior 8-K projected $40 million in annualized savings and a one-time $4 million restructuring charge
- Proxy statement content (definitive additional materials) not available in parsed text form
Financial Impact
Not specified
Risk Factors
- Potential activist campaign or shareholder vote outcome uncertainty
- Restructuring may impact near-term revenue growth
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001376339-26-000037 |
| Document: 0001376339-26-000037-index-headers.html | 0001376339-26-000037 |
| Document: 0001376339-26-000037-index.html | 0001376339-26-000037 |
| Document: 0001376339-26-000037.txt | 0001376339-26-000037 |
Track record
10 reports on MDXG
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +26.86% at T+20 after the Oct 16, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G Neutral 4/10 Entry $3.21 Now $3.18 −0.93% settles Nov 20
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 6/10 Entry $3.97 to $3.28 Now $3.18 +19.90% ▲ +17.38% +12.65% vs SPY
- Oct 28, 202619d ago Press Release Bullish 5/10 Entry $3.97 to $3.28 Now $3.18 −19.90% ▼ −17.38% −12.65% vs SPY
- Oct 16, 20264w ago 425 Mixed 5/10 Entry $4.43 to $3.91 Now $3.18 −28.22% ▼ −11.74% −11.83% vs SPY
- Oct 16, 20264w ago 8-K Bearish 6/10 Entry $4.43 to $3.91 Now $3.18 +28.22% ▲ +11.74% +11.83% vs SPY
- Jun 2, 202624w ago Court Ruling Bullish 5/10 Entry $3.57 to $3.71 Now $3.18 −10.92% ▲ +3.92% +6.89% vs SPY
- Apr 29, 202628w ago DEFA14A Neutral 3/10 Viewing Entry $3.36 to $3.66 Now $3.18 −5.36% ▲ +8.93% +7.20% vs SPY
- Apr 22, 202629w ago Press Release Neutral 1/10 Entry $3.31 to $3.27 Now $3.18 −3.93% ▼ −1.36% −1.41% vs SPY
- Apr 16, 202630w ago 8-K Bearish 7/10 Entry $3.43 to $3.35 Now $3.18 +7.29% ▲ +2.33% +3.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers